AMD is an eye condition resulting in loss of central vision, usually in both eyes. It causes an increasing loss of ability to read and navigate, with associated quality of life issues.
AMD is the leading cause of blindness in adults over 50 in most economically developed nations. Macular degeneration affects over 3% of the global population.
The Clear-K® Treatment is being studied for the treatment of dry and wet AMD and other ocular diseases and disorders and is not approved for sale in the United States. CAUTION Investigational device. Limited by Federal (or the United States) law to investigational use.If you would like to receive updates about clinical studies for the Clear-K® Treatment, please contact us.